Article | July 2, 2019

Managing Risks With Potent Pharmaceutical Products

Source: Pharmaceutics International

By Dr. Thomas S. Ingallinera, R.Ph., Ph.D., Vice President, Technical Support

lab virtual science biologic bioprocess 450x300

As a noticeable shift occurs in the pharmaceutical industry from blockbuster drugs to smaller patient populations, there is an increased focus on targeted therapies in specialized areas, such as oncology, where potent compounds serve a key role in patient treatment. Any drug manufacturing facility handling these compounds must be equipped with the appropriate methods, controls, and expertise to ensure the safety of its employees and the integrity of its product. Managing these risks, though, requires a knowledgeable team as well as the design and implementation of an effective safety program.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Pharmaceutics International